|Bid||26.70 x N/A|
|Ask||26.71 x N/A|
|Day's Range||26.36 - 26.97|
|52 Week Range||19.69 - 38.10|
|Beta (5Y Monthly)||1.14|
|PE Ratio (TTM)||9.39|
|Earnings Date||Feb 23, 2023|
|Forward Dividend & Yield||0.92 (3.51%)|
|Ex-Dividend Date||May 16, 2022|
|1y Target Est||35.32|
Subscribe to Yahoo Finance Plus to view Fair Value for FRE.DE
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Fresenius SE & Co. KGaA ( ETR:FRE ) saw a significant share price rise of over 20% in the past couple of months on the...
(Bloomberg) -- Elliott Investment Management has given a fresh indication that it sees value in an overhaul of Fresenius SE by revealing a short position in the German health-care company’s listed dialysis unit.Most Read from BloombergHow Bad Will Housing Get? The Chill Gripping a Once-Hot Market Offers a TestMalaysia Latest: Muhyiddin Turns Down King on Unity GovernmentElon Musk's 2022 Wealth Loss Exceeds $100 Billion for First TimeFTX Latest: Key Takeaways From Tuesday’s Bankruptcy HearingBeyo